Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber

Allergy and Asthma Proceedings

Volumn 33, Issue 5, 2012, Pages 397-403

  Yamamoto, Heizaburo ^a   Yonekura, Syuji ^a   Sakurai, Daiju ^a   Katada, Koji ^a   Inamine, Ayako ^a   Hanazawa, Toyoyuki ^a   Horiguchi, Shigetoshi ^a   Okamoto, Yoshitaka ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FEXOFENADINE; MOMETASONE FUROATE; NOSE SPRAY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; JAPANESE CEDAR; MALE; NOSE OBSTRUCTION; POLLEN ALLERGY; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SNEEZING; SYMPTOM; TREATMENT DURATION;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ALLERGENS; ANTI-ALLERGIC AGENTS; CEDRUS; CHEMOPREVENTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; POLLEN; PREGNADIENEDIOLS; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; TERFENADINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866752982     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3594     Document Type: Article

References (29)

1. Horak F, Stubner P, Zieglmayer R, et al. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis. Int Arch Allergy Immunol 125:73-79, 2001. (Pubitemid 32511103)
2. Day JH, Briscoe MP, Welsh A, et al. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol 79:533-540, 1997. (Pubitemid 28041818)
3. Krug N, Hohlfeld JM, Geldmacher H, et al. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. Allergy 60:354-359, 2005. (Pubitemid 40293353)
4. Stubner P, Zieglmayer R, and Horak F. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit-The Vienna Challenge Chamber (VCC). Curr Med Res Opin 20:891-902, 2004. (Pubitemid 38821528)
5. Hashiguchi K, Tang H, Fujita T, et al. Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber). Expert Opin Pharmacother 10:523-529, 2009.
6. Patel P, D'Andrea C, and Sacks HJ. Onset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an environmental exposure chamber. Am J Rhinol 21:499-503, 2007. (Pubitemid 47360041)
7. Hohfeld JM, Holland-Letz T, Larbig M, et al. Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions. Clin Exp Allergy 40:998-1006, 2010.
8. Okuda M. Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol 91:288-296, 2003. (Pubitemid 37174163)
9. Kaneko Y, Motohashi Y, Nakamura H, et al. Increasing prevalence of Japanese cedar pollinosis: Meta-regression analysis. Int Arch Allergy Immunol 136:365-371, 2005. (Pubitemid 41094500)
10. Okamoto Y, Horiguchi S, Yamamoto H, et al. Present situation of cedar pollinosis in Japan and its immune responses. Allergol Int 58:155-162, 2009. (Epub March 25, 2009.)
11. Sasaki K, Okamoto Y, Yonekura S, et al. Cedar and cypress pollinosis and allergic rhinitis: Quality of life effects of early intervention with leukotriene receptor antagonists. Int Arch Allergy Immunol 149:350-358, 2009.
12. Yonekura S, Okamoto Y, Okubo K, et al. Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting. J Investig Allergol Clin Immunol 19:195-203, 2009.
13. Yamamoto H, Yamada T, Sakashita M, et al. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy Asthma Proc 33:17-22, 2012.
14. Practical Guideline for the Management of Allergic Rhinitis in Japan - Perennial Rhinitis and Pollinosis - 2005 Edition (the 5th revision), Life Science Publishing Co., Ltd., Tokyo, Japan, 32-56, 2005.
15. Weiner JM, Abramson MJ, and Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ 317:1624-1629, 1998. (Pubitemid 28554544)
16. Fitzsimons CP, Monczor F, Fernández N, et al. Mepyramine, a histamine H1 receptor inverse agonist a, binds preferentially to a G protein-coupled Form of the receptor and sequesters G protein. J Biol Chem 279:34431-34439, 2004. (Pubitemid 39318069)
17. Ministry of Health, Labour and Welfare, Japan. Ethical Guidelines for Clinical Studies 2004. http://www.mhlw.go.jp/general/seido/kousei/i-kenkyu/ rinri/0504sisin.html.
18. Ministry of Health, Labour and Welfare, Japan. Ethical Guidelines for Good Clinical Practice 2006. http://www.mhlw.go.jp/shingi/2006/05/dl/s0525-4h. pdf.
19. World Medical Association. WMA Declaration of Helsinki (Ethical Principles for Medical Research Involving Human Subjects) 2000. http://www.wma.net/en/30publications/10policies/b3/.
20. Hashiguchi K, Tang H, Fujita T et al. Validation study of the OHIO chamber in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol 149:141-149, 2009.
21. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 313:65-70, 1985. (Pubitemid 15068698)
22. Gerth van Wijk RG, de Graaf-in 't Veld, Gand arrelds IM. Nasal hyperreactivity. Rhinology 37:50-55, 1999.
23. D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy 62:976-990, 2007. (Pubitemid 47220965)
24. Woods L, and Craig TJ. The importance of rhinitis on sleep, daytime somnolence, productivity and fatigue. Curr Opin Pulm Med 12:390-396, 2006. (Pubitemid 44624596)
25. Leger D, Annesi-Maesano I, and Carat F. Allergic rhinitis and its consequences on quality of sleep. Arch lntern Med 166:1744-1748, 2006.
26. Yamamoto H, Yamada T, Kubo S, et al. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study. Allergy Asthma Proc 31:296-303, 2010.
27. Ciprandi G, Cosentino C, Milanese M, et al. Fexofenadine reduces nasal congestion in perennial allergic rhinitis. Allergy 56:1068-1070, 2001. (Pubitemid 33020647)
28. Vena GA, Cassano N, Buquicchio R, and Ventura MT. Antiinflammatory effects of H1-antihistamines: Clinical and immunological relevance. Curr Pharm Des 14:2902-2911, 2008.
29. Bachert C. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Clin Ther 31:921-944, 2009.